Common treatment for multiple sclerosis may prolong life

Researchers from the University of British Columbia and Vancouver Coastal Health Research Institute have found that a widely prescribed drug for multiple sclerosis (MS) is associated with longer survival for patients.

The study, published today in the journal Brain, found that people with MS who took a beta interferon drug had a 32 per cent lower mortality risk than those that did not take the drug. This was particularly evident among MS patients who took beta interferon for more than three years.


https://www.sciencedaily.com/releases/2019/03/190318132638.htm

More Posts

De 1000 ansigter – Vivi Mikkelsen

Navn:Vivi Mikkelsen Alder:53 Bor i:Hvam 8620 Kjellerup Hvornår fik du din diagnose?November 17 Hvad var dine første symptomer?Nedsat kraft og føleforstyrrelser. Kognitiv svækkelse ved bl.a.

Sjælens barn

Sjælens barn: Den smilende facade Værner om hjertets ballade. Nede i ensomhedens kælder De tårer jeg indvendig fælder. I materialismens borg Vokser livets sorg. Med

Sclerose, varme, kognition

Hvad kan der ske når vamen spiller ind for ens kognitive forhold eller symptomer.Det er en naturlig reaktion, når varmen kommer